[go: up one dir, main page]

AU2008231305A1 - Genetics variants associated with HIV disease restriction - Google Patents

Genetics variants associated with HIV disease restriction Download PDF

Info

Publication number
AU2008231305A1
AU2008231305A1 AU2008231305A AU2008231305A AU2008231305A1 AU 2008231305 A1 AU2008231305 A1 AU 2008231305A1 AU 2008231305 A AU2008231305 A AU 2008231305A AU 2008231305 A AU2008231305 A AU 2008231305A AU 2008231305 A1 AU2008231305 A1 AU 2008231305A1
Authority
AU
Australia
Prior art keywords
patient
hiv
minor allele
aids
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008231305A
Other languages
English (en)
Inventor
Jacques Fellay
Dongliang Ge
David B. Goldstein
Barton F. Haynes
Kevin V. Shianna
Amalio Telenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Lausanne
Duke University
Original Assignee
Universite de Lausanne
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Lausanne, Duke University filed Critical Universite de Lausanne
Publication of AU2008231305A1 publication Critical patent/AU2008231305A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2008231305A 2007-03-27 2008-03-27 Genetics variants associated with HIV disease restriction Abandoned AU2008231305A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US90727107P 2007-03-27 2007-03-27
US60/907,271 2007-03-27
US92943207P 2007-06-27 2007-06-27
US60/929,432 2007-06-27
PCT/US2008/003964 WO2008118469A2 (fr) 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih

Publications (1)

Publication Number Publication Date
AU2008231305A1 true AU2008231305A1 (en) 2008-10-02

Family

ID=39789200

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008231305A Abandoned AU2008231305A1 (en) 2007-03-27 2008-03-27 Genetics variants associated with HIV disease restriction

Country Status (5)

Country Link
EP (1) EP2121985A4 (fr)
JP (1) JP2010522560A (fr)
AU (1) AU2008231305A1 (fr)
CA (1) CA2680834A1 (fr)
WO (1) WO2008118469A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105316417B (zh) * 2015-11-27 2018-11-30 北京泱深生物信息技术有限公司 Znrd1基因及其表达产物作为颅内动脉瘤的诊治靶标
AU2017375590A1 (en) * 2016-12-14 2019-06-13 Beijing Genomics Institute At Shenzhen Human genetic markers associated with response to treatments that target Clostridium difficile toxin B

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130152A2 (fr) * 2004-11-26 2006-12-07 Board Of Regents, University Of Texas System Methodes et compositions de mise en correlation des genotypes ccl3l1/ccr5 avec certains troubles

Also Published As

Publication number Publication date
WO2008118469A2 (fr) 2008-10-02
EP2121985A4 (fr) 2011-01-05
EP2121985A2 (fr) 2009-11-25
WO2008118469A3 (fr) 2008-12-24
CA2680834A1 (fr) 2008-10-02
JP2010522560A (ja) 2010-07-08

Similar Documents

Publication Publication Date Title
Jawaheer et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis
Li et al. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons
Fellay et al. Common genetic variation and the control of HIV-1 in humans
Pelak et al. Copy number variation of KIR genes influences HIV-1 control
Piacentini et al. Genetic correlates of protection against HIV infection: the ally within
Lerner et al. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy
Natividad et al. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection
US7858319B2 (en) Method of screening for drug hypersensitivity reaction
Hart et al. Quantitative gene expression profiling implicates genes for susceptibility and resistance to alveolar bone loss
Luque et al. Gene expression profile in long-term non progressor HIV infected patients: in search of potential resistance factors
Schreurs et al. Autophagy-enhancing ATG16L1 polymorphism is associated with improved clinical outcome and T-cell immunity in chronic HIV-1 infection
Schughart et al. Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response
AU2008231305A1 (en) Genetics variants associated with HIV disease restriction
Gourraud et al. APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus–1 infection
Ahir et al. Genetic variation in the promoter region of pro-inflammatory cytokine TNF-α in perinatal HIV transmission from Mumbai, India
AU2009236629A1 (en) Genetics variants associated with HIV disease restriction
Casado et al. High-risk sexual practices contribute to HIV-1 double infection among men who have sex with men in Madrid
Bratosiewicz‐Wąsik et al. The effect of TRIM5 variants on the susceptibility to HIV‐1 infection and disease progression in the Polish population
Pourakbari et al. Association between interleukin 2 receptor A gene polymorphisms (rs2104286 and rs12722489) with susceptibility to multiple sclerosis in Iranian population
WO2003018745A2 (fr) Procede de depistage des reactions d'hypersensibilite a des medicaments
Teruel et al. An integrative multi-omics approach in Sjögren’s Syndrome identifies novel genetic drivers with regulatory function and disease-specificity
WO2009103992A1 (fr) Variation génétique associée à la maladie coeliaque
Notani Prevalence of 𝘈𝘗𝘖𝘓1 risk variants in HIV-positive compared to HIV-negative individuals with evidence of kidney disease
Davis Host genetic and epigenetic determinants that mediate differential outcome in HIV-2 in West Africa
Canady Novel Approaches to Uncover Host Genetic Correlates of Human Immunodeficiency Virus Disease Progression

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period